Abstract
Mammalian cells have been microencapsulated within both natural and synthetic polymers for over half a century. Specifically, in the last 36 years microencapsulated cells have been used therapeutically to deliver a wide range of drugs, cytokines, growth factors, and hormones while enjoying the immunoisolation provided by the encapsulating material. In addition to preventing immune attack, microencapsulation prevents migration of entrapped cells. Cells can be microencapsulated in a variety of geometries, the most common being solid microspheres and hollow microcapsules. The micrometer scale permits delivery by injection and is within diffusion limits that allow the cells to provide the necessary factors that are missing at a target site, while also permitting the exchange of nutrients and waste products. The majority of cell microencapsulation is performed with alginate/poly-l-lysine microspheres. Since alginate itself can be immunogenic, for cell-based therapy applications various groups are investigating synthetic polymers to microencapsulate cells. We describe a protocol for the formation of microspheres and microcapsules using the synthetic polymer poly(ethylene glycol) diacrylate (PEGDA).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zhang JJ (2013) Mechanisms of cell therapy for clinical investigations: an urgent need for large-animal models. Circulation 128:92–94
Kim JK et al (2010) Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. Cell Transplant 19:1237–1246
Camussi G, Dereqibus MC, Tetta C (2010) Paracrine/endocrine mechanism of stem cells on kidney repair: role of microvesicle-mediated transfer of genetic information. Curr Opin Nephrol Hypertens 19(1):7–12
Abumaree M, Al Jumah M, Pace RA, Kalionis B (2012) Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev 8(2):375–392
Moutsatsos IK et al (2001) Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 3:449–461
Goren A, Dahan N, Goren E et al (2010) Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy. FASEB J 24(1):22–31
Ausländer S, Wieland M, Fussenegger M (2012) Smart medication through combination of synthetic biology and cell microencapsulation. Metab Eng 14(3):252–260
Tomaro-Duchesneau C, Saha S, Malhotra M et al (2013) Microencapsulation for the therapeutic delivery of drugs, live mammalian and bacterial cells, and other biopharmaceutics: current status and future directions. J Pharm 2013:103527
Teramura Y, Minh LN, Kawamoto T, Hiroo Iwata H (2010) Microencapsulation of islets with living cells using PolyDNA-PEG-lipid conjugate. Bioconjugate Chem 21(4):792–796
Olabisi RM, Lazard ZW, Franco CL et al (2010) Hydrogel microsphere encapsulation of a cell-based gene therapy system increases cell survival of injected cells, transgene expression, and bone volume in a model of heterotopic ossification. Tissue Eng Part A 16(12):3727–3736
Afkhami F, Yves Durocher Y, Satya Prakash S (2010) Investigation of antiangiogenic tumor therapy potential of microencapsulated HEK293 VEGF165b producing cells. J Biomed Biotechnol 2010:645610
Chang TMS, Macintosh FC, Mason SG (1966) Semipermeable aqueous microcapsules: I. Preparation and properties. Can J Physiol Pharmacol 44:115–128
Lim F, Sun AM (1980) Microencapsulated islets as bioartificial endocrine pancreas. Science 210:908–910
Olabisi RM (2015) Cell microencapsulation with synthetic polymers. Tissue Eng Pt A 103:846–859
Hong JS, Shin SJ, Lee S, Wong E et al (2007) Spherical and cylindrical microencapsulation of living cells using microfluidic devices. Korea Aust Rheol J 19(3):157–164
Hunt NC, Grover LM (2010) Cell encapsulation using biopolymer gels for regenerative medicine. Biotechnol Lett 32(6):733–742
Liu L, Shujun Gao S, Yu Y et al (2006) Bio-ceramic hollow fiber membranes for immunoisolation and gene delivery: I: membrane development. J Membrane Sci 280:375–382
Baker J. A phase I/IIa open-label investigation of the safety and effectiveness of DIABECELL(R) [immunoprotected (alginate-encapsulated) porcine islets for Xenotransplantation] in patients with type I diabetes mellitus (study NCT00940173). Available at: http://www.clinicaltrials.gov. Accessed 18 Sept 2015
Dufrane D. A monocentre phase 1 trial to assess a monolayer cellular device in the treatment of type 1 diabetes (study NCT00790257). Available at: http://www.clinicaltrials.gov. Accessed 18 Sept 2015
Keymeulen B. Functional survival of beta cell allografts after transplantation in the peritoneal cavity of non-uremic type 1 diabetic patients (study NCT01379729). Available at: http://www.clinicaltrials.gov. Accessed 18 Sept 2015
Schwartz S, Mulgrew P. A single-center phase I/II study of PEG-encapsulated islet allografts implanted in patients with type I diabetes (study NCT00260234). Available at: http://www.clinicaltrials.gov. Accessed 18 Sept 2015
Bryant SJ, Anseth KS (2002) Hydrogel properties influence ECM production by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels. J Biomed Mater Res 59:63–72
Tibbitt MW, Anseth KS (2009) Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng 103:655–663
Aijaz A, Faulknor R, Berthiaume F, Olabisi RM (2015) Hydrogel microencapsulated insulin-secreting cells increase keratinocyte migration, epidermal thickness, collagen fiber density, and wound closure in a diabetic mouse model of wound healing. Tissue Eng Part A. doi:10.1089/ten.TEA.2015.0069
Franco CL, Price J, West JL (2011) Development and optimization of a dual-photoinitiator, emulsion-based technique for rapid generation of cell-laden hydrogel microspheres. Acta Biomater 7(9):3267–3276
Mumaw J, Jordan ET, Sonnet C et al (2012) Rapid heterotrophic ossification with cryopreserved poly(ethylene glycol-) microencapsulated BMP2-expressing MSCs. Int J Biomater 2012:861794
Sonnet C, Simpson CL, Olabisi RM et al (2013) Rapid healing of femoral defects in rats with low dose sustained BMP2 expression from PEGDA hydrogel microspheres. J Orthop Res 31(10):1597–1604
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Aijaz, A., Perera, D., Olabisi, R.M. (2017). Polymeric Materials for Cell Microencapsulation. In: Opara, E. (eds) Cell Microencapsulation. Methods in Molecular Biology, vol 1479. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6364-5_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6364-5_6
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6362-1
Online ISBN: 978-1-4939-6364-5
eBook Packages: Springer Protocols